You have 9 free searches left this month | for more free features.

residual c-peptide

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

Recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 18, 2023

Phantom Limb Pain, Neuroma Amputation Trial in Salt Lake City (Cooled Radiofrequency Ablation)

Active, not recruiting
  • Phantom Limb Pain
  • Neuroma Amputation
  • Cooled Radiofrequency Ablation
  • Salt Lake City, Utah
    University of Utah
Dec 3, 2022

Carotid Atherosclerosis Trial in Saint Louis (Cu[64]-25%-CANF-Comb PET-MR)

Completed
  • Carotid Atherosclerosis
  • Cu[64]-25%-CANF-Comb PET-MR
  • Saint Louis, Missouri
    Washington University in St.Louis
Oct 13, 2022

Colorectal Cancer Trial (EO2040)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 26, 2022

Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Prolonged-Release Pirfenidone
  • Guadalajara, Jalisco, Mexico
  • +1 more
Sep 13, 2022

Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease, Elderly Patients Trial in Beijing (colchicine)

Not yet recruiting
  • Percutaneous Coronary Intervention
  • +3 more
  • Beijing, Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, CAM
Sep 1, 2023

Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)

Recruiting
  • Colon Cancer
  • Resected Stage
  • Houston, Texas
    M D Anderson Cancer Center
Jul 23, 2022

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Basal Cell Carcinoma Trial in Miami (Optical Coherence Tomography (OCT), Curettage & Desiccation (C&D) Procedure)

Not yet recruiting
  • Basal Cell Carcinoma
  • Optical Coherence Tomography (OCT)
  • Curettage & Desiccation (C&D) Procedure
  • Miami, Florida
    University of Miami
Apr 26, 2022

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Recruiting
  • Carotid Atherosclerosis
  • +2 more
  • Los Angeles, California
  • +1 more
Apr 27, 2023

Polycystic Ovary Syndrome, c Type Natriuretic Peptide, Menstrual Irregularity Trial in Nicosia (C type natriuretic peptide)

Completed
  • Polycystic Ovary Syndrome
  • +3 more
  • C type natriuretic peptide
  • Nicosia, Cyprus
    Near East University Faculty of Medicine
Oct 7, 2021

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Development ofNovel Method to Measure Insulin Sensitivity in

Completed
  • Insulin Sensitivity
  • 24h Continuous glucose monitoring and urinary C-peptide collection
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Jun 12, 2022

Clinical Performance Evaluation of the C2i Test

Not yet recruiting
  • Muscle Invasive Bladder Cancer
  • C2i-WGS-MRD Test
  • (no location specified)
May 5, 2023

Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

Completed
  • Hiv
  • Autologous CD4 T-Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 13, 2022

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

Not yet recruiting
  • Non-small Cell Lung Cancer
  • NGS and ctDNA-MRD detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023

Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)

Active, not recruiting
  • Post Concussive Symptoms
  • Early intervention programme
  • Enhanced usual care
  • (no location specified)
Apr 11, 2023

Development of Predictive Biomarkers

Completed
  • Type1diabetes
  • Mixed Meal Tolerance Test
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Nov 28, 2021

Healthy Trial (Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide, Peptide complexed HA Age Defying Gel with

Not yet recruiting
  • Healthy
  • Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide
  • +4 more
  • (no location specified)
Dec 11, 2022

Patients With Colorectal Cancer, the MiRDA-C Study

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Gilbert, Arizona
  • +8 more
Aug 16, 2022

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)

Completed
  • Alcohol Use Disorder
  • Pittsburgh, Pennsylvania
    University of PIttsburgh PET Facility
Jul 8, 2022

Hyperlipidemias Trial in Toronto (Teduglutide, Placebo)

Completed
  • Hyperlipidemias
  • Toronto, Ontario, Canada
  • +1 more
May 18, 2022